On Monday, Clover Health Investments Corp (NASDAQ: CLOV) was -6.29%% drop from the session before settling in for the closing price of $3.02. A 52-week range for CLOV has been $1.13 – $4.87.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -237.67% over the past five years. When this article was written, the company’s average yearly earnings per share was at 36.85%. With a float of $382.25 million, this company’s outstanding shares have now reached $388.51 million.
Let’s look at the performance matrix of the company that is accounted for 570 employees. In terms of profitability, gross margin is 26.37%, operating margin of -1.64%, and the pretax margin is -1.64%.
Clover Health Investments Corp (CLOV) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Clover Health Investments Corp stocks. The insider ownership of Clover Health Investments Corp is 24.89%, while institutional ownership is 20.90%. The most recent insider transaction that took place on Jun 17 ’25, was worth 58,487. In this transaction CEO, Medicare Advantage of this company sold 20,450 shares at a rate of $2.86, taking the stock ownership to the 3,196,401 shares. Before that another transaction happened on Jun 17 ’25, when Company’s Officer proposed sale 20,450 for $2.92, making the entire transaction worth $59,714.
Clover Health Investments Corp (CLOV) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 36.85% per share during the next fiscal year.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
You can see what Clover Health Investments Corp (CLOV) is doing with its current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.05, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.02 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
Clover Health Investments Corp (NASDAQ: CLOV) saw its 5-day average volume 8.13 million, a positive change from its year-to-date volume of 6.11 million. As of the previous 9 days, the stock’s Stochastic %D was 43.65%.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 2.48%, which indicates a significant decrease from 12.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.36% in the past 14 days, which was lower than the 52.83% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.31, while its 200-day Moving Average is $3.57. Nevertheless, the first resistance level for the watch stands at $2.95 in the near term. At $3.06, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.15. If the price goes on to break the first support level at $2.75, it is likely to go to the next support level at $2.66. The third support level lies at $2.55 if the price breaches the second support level.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
There are 508,917K outstanding shares of the company, which has a market capitalization of 1.44 billion. As of now, sales total 1,371 M while income totals -43,010 K. Its latest quarter income was 462,330 K while its last quarter net income were -1,270 K.
